Agnieszka K. Witkiewicz

Roswell Park Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity”.

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2381

N/A

0.749DataRank · unranked

146 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

Determinants of response to CDK4/6 inhibitors in the real-world setting

npj Precision Oncology(2023)10.1038/s41698-023-00438-0

N/A

0.745DataRank · unranked

25 citations

Emily Schultz, Jianxin Wang, Deanna Hamilton, Ellis Levine, Tracey L. O’Connor +2 more

Targeting CDK2 for cancer therapy

Cell Reports(2025)10.1016/j.celrep.2025.116140

N/A

0.500DataRank · unranked

27 citations

Agnieszka K. Witkiewicz, Ioannis Sanidas, Seth M. Rubin, Erik S. Knudsen

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007381

N/A

0.442DataRank · unranked

18 citations

Mateusz Opyrchal, Melissa Grimm, Ronald Slomba, Kathleen M. Kokolus, Agnieszka K. Witkiewicz +13 more

Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation

Cell Reports(2023)10.1016/j.celrep.2023.112250

N/A

0.437DataRank · unranked

10 citations

Takemasa Tsuji, Cameron R. MacDonald, Joseph L. Sarow, Hanna R. Rosenheck, Saeed Daneshmandi +10 more

Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0369

N/A

0.330DataRank · unranked

8 citations

Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo, Katerina V. Gurova, Erik S. Knudsen +2 more

Baseline cell cycle and immune profiles indicate CDK4/6 inhibitor response in metastatic HR + /HER2- breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00767-2

N/A

0.312DataRank · unranked

5 citations

Emily Schultz, Jianxin Wang, Hanna R. Rosenheck, Sidney Mahan, Erik S. Knudsen +2 more

p16 expression confers sensitivity to CDK2 inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.10.637344

N/A

0.241DataRank · unranked

4 citations

Lotte P. Watts, Brianna Fernandez, Jianxin Wang, Erik S. Knudsen, Agnieszka K. Witkiewicz +2 more

Data from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

(2023)10.1158/1078-0432.c.6530279

N/A

0DataRank · unranked

0 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0426

N/A

0DataRank · unranked

147 citations

John Baer, Douglas V. Faget, Vasilios A. Morikis, Qihao Ren, Anupama Melam +14 more

The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-2504

N/A

0DataRank · unranked

48 citations

Jianxin Wang, Costakis Frangou, Yin Wan, Andrew Dynka, Hanna R. Rosenheck +5 more

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

UNC Libraries(2024)10.17615/2caa-2659

N/A

0DataRank · unranked

24 citations

Daniel Zeitouni, Clint A. Stalnecker, Haoqiang Ying, Erik S. Knudsen, Guofang Zhang +26 more

Separable cell cycle arrest and immune response elicited through pharmacological CDK4/6 and MEK inhibition in RASmut disease models

Research Square(2024)10.21203/rs.3.rs-4138843/v1

N/A

0DataRank · unranked

0 citations

Jin Wu, Jianxin Wang, T O'Connor, Stephanie L. Tzetzo, Katerina V. Gurova +2 more

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle

Nature Communications(2025)10.1038/s41467-025-56674-4

N/A

0DataRank · unranked

35 citations

Jianxin Wang, Michelle Roti, Yin Wan, Adam P. Dommer, Hanna R. Rosenheck +11 more

p16 expression confers sensitivity to CDK2 inhibitors in cyclin E1–driven ovarian cancers

Science Signaling(2025)10.1126/scisignal.adv0415

N/A

0DataRank · unranked

4 citations

Lotte P. Watts, Brianna Fernandez, Nasreen Marikar, Jianxin Wang, Erik S. Knudsen +3 more

RB loss sensitizes triple-negative breast cancer to apoptosis induced by cellular stress

Cell Death Discovery(2025)10.1038/s41420-025-02864-4

N/A

0DataRank · unranked

2 citations

Subrahmanya Anirudh Kaligotla Venkata, Erik S. Knudsen, Vishnu Kumarasamy, Agnieszka K. Witkiewicz

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma

Molecular Cancer(2025)10.1186/s12943-025-02408-5

N/A

0DataRank · unranked

3 citations

Kennedy S. Humphrey, Eduardo Cortes Gomez, Jianxin Wang, Vishnu Kumarasamy, Yin Wan +7 more

Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.06.636643

N/A

0DataRank · unranked

1 citations

K. Humphrey, Eduardo Cortes Gomez, Jianxin Wang, Michael E. Feigin, Agnieszka K. Witkiewicz +3 more

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs

UNC Libraries(2020)10.17615/jbap-cx13

N/A

0DataRank · unranked

0 citations

Charles J. Yeo, L. Jay Katz, Clay E.S. Comstock, George L. Spaeth, Lisa Hark +22 more

Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine

UNC Libraries(2020)10.17615/emqc-jb75

N/A

0DataRank · unranked

0 citations

Kimberly J. Briggs, Agnieszka K. Witkiewicz, Shugeng Cao, Benjamin F. Cravatt, Keriann M. Backus +9 more

Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity

Cancer Cell(2021)10.1016/j.ccell.2021.06.016

N/A

0DataRank · unranked

175 citations

Katherine Huang, Marek Pacal, Sean R. McCurdy, Suying Lü, Arthur Aubry +21 more

CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities

Cell Reports(2022)10.1016/j.celrep.2022.110448

N/A

0DataRank · unranked

134 citations

Vishnu Kumarasamy, Ram Nambiar, Joel D. Pearson, Paris Vail, Hanna R. Rosenheck +8 more

Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy

Trends in cancer(2022)10.1016/j.trecan.2022.04.006

N/A

0DataRank · unranked

51 citations

Vishnu Kumarasamy, Ioannis Sanidas, Erik S. Knudsen, Agnieszka K. Witkiewicz

Cancer takes many paths through G1/S

Trends in Cell Biology(2023)10.1016/j.tcb.2023.10.007

N/A

0DataRank · unranked

51 citations

Agnieszka K. Witkiewicz, Seth M. Rubin, Erik S. Knudsen

Pharmacologically targeting KRAS G12D in PDAC models: tumor cell intrinsic and extrinsic impact

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.18.533261

N/A

0DataRank · unranked

3 citations

Costakis Frangou, Jianxin Wang, Yin Wan, Andrew Dynka, Hanna R. Rosenheck +5 more